NEW YORK, Jan 16 - A German venture capital fund has purchased an eight percent stake in Chicago-based Integrated Genomics, which specializes in sequence-based cell function modeling, as well as DNA extraction, cosmid and plasmid gene libraries, and sequencing, the fund, Deutsche Effecten-und Wechsel Beteiligungssgesellschaft, AG, announced Tuesday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.